Australia Cardiovascular Devices Market Outlook to 2020 Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others On 8th August 2014
Australia Cardiovascular Devices Market Outlook to 2020, provides key market data on the Australia Cardiovascular Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories – Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. Browse Full Report @ http://www.jsbmarketresearch.com/healthcare-medical/r-AustraliaCardiovascular-Devices-Market-Outlook-to-2020-Cardiac-Rhythm-Management-InterventionalCardiology-Peripheral-Vascular-Devices-Electrophysiology-Prosthetic-Heart-Valves-and-Others114978 The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Devices market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment–based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment–based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope Market size and company share data for Cardiovascular Devices categories – Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. 2012 company shares and distribution shares data for each of the market categories. Global corporate-level profiles of key companies operating within the Australia Cardiovascular Devices market. Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories, Cordis Corporation, C.R. Bard, Inc., Thoratec Corporation, Philips Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Healthcare, Sorin Group, MAQUET GmbH & Co. KG, Edwards Lifesciences Corporation, Terumo Corporation and BIOTRONIK SE & Co. KG.
Reasons To Buy Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. Develop market-entry and market expansion strategies. Design competition strategies by identifying who-stands-where in the market. Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Table of Content 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 What Is This Report About? 2.2 Cardiovascular Devices Market Segmentation 2.3 Definitions of Markets Covered in the Report 3 Cardiovascular Devices Market, Australia 3.1 Cardiovascular Devices Market, Australia, Revenue ($m), 2005-2020 3.2 Cardiovascular Devices Market, Australia, Revenue Mix ($m), 2012 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
3.3 Cardiovascular Devices Market, Australia, Category Contribution by Revenue ($m), 2012 3.4 Cardiovascular Devices Market, Australia, Category Comparison by Revenue ($m), 20052020 3.5 Cardiovascular Devices Market, Australia, Revenue ($m), 2005-2012 3.6 Cardiovascular Devices Market, Australia, Revenue ($m), 2012-2020 3.7 Cardiovascular Devices Market, Australia, Volume (Units), 2005-2020 3.8 Cardiovascular Devices Market, Australia, Volume (Units), 2005-2012 3.9 Cardiovascular Devices Market, Australia, Volume (Units), 2012-2020 3.10 Cardiovascular Devices Market, Australia, Company Share by Revenue ($m), 2011-2012 4 Cardiac Assist Devices Market, Australia 4.1 Cardiac Assist Devices Market, Australia, Revenue Mix ($m), 2012 4.2 Cardiac Assist Devices Market, Australia, Segment Contribution (%), 2012 4.3 Cardiac Assist Devices Market, Australia, Revenue ($m), by Segment, 2005-2012 4.4 Cardiac Assist Devices Market, Australia, Revenue ($m) by Segment, 2012-2020 4.5 Cardiac Assist Devices Market, Australia, Volume (Units) by Segment, 2005-2012 4.6 Cardiac Assist Devices Market, Australia, Volume (Units) by Segment, 2012-2020 4.7 Cardiac Assist Devices Market, Australia, Distribution Share, Revenue ($m), 2011-2012 4.8 Cardiac Assist Devices Market, Australia, Company Share by Revenue ($m), 2011-2012 5 Cardiac Rhythm Management Market, Australia 5.1 Cardiac Rhythm Management Market, Australia, Revenue Mix ($m), 2012 5.2 Cardiac Rhythm Management Market, Australia, Segment Contribution (%), 2012 5.3 Cardiac Rhythm Management Market, Australia, Revenue ($m), by Segment, 2005-2012 5.4 Cardiac Rhythm Management Market, Australia, Revenue ($m) by Segment, 2012-2020 5.5 Cardiac Rhythm Management Market, Australia, Volume (Units) by Segment, 2005-2012 5.6 Cardiac Rhythm Management Market, Australia, Volume (Units) by Segment, 2012-2020 5.7 Cardiac Rhythm Management Market, Australia, Distribution Share, Revenue ($m), 20112012 5.8 Cardiac Rhythm Management Market, Australia, Company Share by Revenue ($m), 20112012 6 Cardiovascular Monitoring and Diagnostic Devices Market, Australia 6.1 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue ($m), by Segment, 2005-2012 6.2 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue ($m) by Segment, 2012-2020 6.3 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Volume (Units) by Segment, 2005-2012 6.4 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Volume (Units) by Segment, 2012-2020 6.5 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Distribution Share, Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Revenue ($m), 2011-2012 6.6 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Company Share by Revenue ($m), 2011-2012 7 Cardiovascular Prosthetic Devices Market, Australia 7.1 Cardiovascular Prosthetic Devices Market, Australia, Revenue Mix ($m), 2012 7.2 Cardiovascular Prosthetic Devices Market, Australia, Segment Contribution (%), 2012 7.3 Cardiovascular Prosthetic Devices Market, Australia, Revenue ($m), by Segment, 2005-2012 7.4 Cardiovascular Prosthetic Devices Market, Australia, Revenue ($m) by Segment, 2012-2020 7.5 Cardiovascular Prosthetic Devices Market, Australia, Volume (Units) by Segment, 20052012 7.6 Cardiovascular Prosthetic Devices Market, Australia, Volume (Units) by Segment, 20122020 7.7 Cardiovascular Prosthetic Devices Market, Australia, Distribution Share, Revenue ($m), 2011-2012 7.8 Cardiovascular Prosthetic Devices Market, Australia, Company Share by Revenue ($m), 2011-2012 8 Cardiovascular Surgery Market, Australia 8.1 Cardiovascular Surgery Market, Australia, Revenue Mix ($m), 2012 8.2 Cardiovascular Surgery Market, Australia, Segment Contribution (%), 2012 8.3 Cardiovascular Surgery Market, Australia, Revenue ($m), by Segment, 2005-2012 8.4 Cardiovascular Surgery Market, Australia, Revenue ($m) by Segment, 2012-2020 8.5 Cardiovascular Surgery Market, Australia, Volume (Units) by Segment, 2005-2012 8.6 Cardiovascular Surgery Market, Australia, Volume (Units) by Segment, 2012-2020 8.7 Cardiovascular Surgery Market, Australia, Distribution Share, Revenue ($m), 2011-2012 8.8 Cardiovascular Surgery Market, Australia, Company Share by Revenue ($m), 2011-2012 9 Electrophysiology Market, Australia 9.1 Electrophysiology Market, Australia, Revenue Mix ($m), 2012 9.2 Electrophysiology Market, Australia, Segment Contribution (%), 2012 9.3 Electrophysiology Market, Australia, Revenue ($m), by Segment, 2005-2012 9.4 Electrophysiology Market, Australia, Revenue ($m) by Segment, 2012-2020 9.5 Electrophysiology Market, Australia, Volume (Units) by Segment, 2005-2012 9.6 Electrophysiology Market, Australia, Volume (Units) by Segment, 2012-2020 9.7 Electrophysiology Market, Australia, Distribution Share, Revenue ($m), 2011-2012 9.8 Electrophysiology Market, Australia, Company Share by Revenue ($m), 2011-2012 10 External Defibrillators Market, Australia 10.1 External Defibrillators Market, Australia, Revenue ($m), by Segment, 2005-2012 10.2 External Defibrillators Market, Australia, Revenue ($m) by Segment, 2012-2020 10.3 External Defibrillators Market, Australia, Volume (Units) by Segment, 2005-2012 10.4 External Defibrillators Market, Australia, Volume (Units) by Segment, 2012-2020 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
10.5 External Defibrillators Market, Australia, Distribution Share, Revenue ($m), 2011-2012 10.6 External Defibrillators Market, Australia, Company Share by Revenue ($m), 2011-2012 11 Interventional Cardiology Market, Australia 11.1 Interventional Cardiology Market, Australia, Revenue Mix ($m), 2012 11.2 Interventional Cardiology Market, Australia, Segment Contribution (%), 2012 11.3 Interventional Cardiology Market, Australia, Revenue ($m), by Segment, 2005-2012 11.4 Interventional Cardiology Market, Australia, Revenue ($m) by Segment, 2012-2020 11.5 Interventional Cardiology Market, Australia, Volume (Units) by Segment, 2005-2012 11.6 Interventional Cardiology Market, Australia, Volume (Units) by Segment, 2012-2020 11.7 Interventional Cardiology Market, Australia, Distribution Share, Revenue ($m), 2011-2012 11.8 Interventional Cardiology Market, Australia, Company Share by Revenue ($m), 2011-2012 12 Peripheral Vascular Devices Market, Australia 12.1 Peripheral Vascular Devices Market, Australia, Revenue Mix ($m), 2012 12.2 Peripheral Vascular Devices Market, Australia, Segment Contribution (%), 2012 12.3 Peripheral Vascular Devices Market, Australia, Revenue ($m), by Segment, 2005-2012 12.4 Peripheral Vascular Devices Market, Australia, Revenue ($m) by Segment, 2012-2020 12.5 Peripheral Vascular Devices Market, Australia, Volume (Units) by Segment, 2005-2012 12.6 Peripheral Vascular Devices Market, Australia, Volume (Units) by Segment, 2012-2020 12.7 Peripheral Vascular Devices Market, Australia, Distribution Share, Revenue ($m), 20112012 12.8 Peripheral Vascular Devices Market, Australia, Company Share by Revenue ($m), 20112012 13 Prosthetic Heart Valves Market, Australia 13.1 Prosthetic Heart Valves Market, Australia, Revenue Mix ($m), 2012 13.2 Prosthetic Heart Valves Market, Australia, Segment Contribution (%), 2012 13.3 Prosthetic Heart Valves Market, Australia, Revenue ($m), by Segment, 2005-2012 13.4 Prosthetic Heart Valves Market, Australia, Revenue ($m) by Segment, 2012-2020 13.5 Prosthetic Heart Valves Market, Australia, Volume (Units) by Segment, 2005-2012 13.6 Prosthetic Heart Valves Market, Australia, Volume (Units) by Segment, 2012-2020 13.7 Prosthetic Heart Valves Market, Australia, Distribution Share, Revenue ($m), 2011-2012 13.8 Prosthetic Heart Valves Market, Australia, Company Share by Revenue ($m), 2011-2012 14 Overview of Key Companies in Australia, Market 14.1 Medtronic, Inc. 14.1.1 Company Overview 14.2 Boston Scientific Corporation 14.2.1 Company Overview 14.3 St. Jude Medical, Inc. 14.3.1 Company Overview 14.4 Abbott Laboratories Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
14.4.1 Company Overview 14.5 Sorin S.p.A. 14.5.1 Company Overview 14.6 Terumo Corporation 14.6.1 Company Overview 14.7 Maquet Holding B.V. & Co. KG. 14.7.1 Company Overview 14.8 Biotronik SE & Co. KG 14.8.1 Company Overview 14.9 Edwards Lifesciences Corporation 14.9.1 Company Overview 14.10 Cordis Corporation 14.10.1 Company Overview 14.11 Thoratec Corporation 14.11.1 Company Overview 14.12 Biosense Webster, Inc. 14.12.1 Company Overview 14.13 Philips Healthcare 14.13.1 Company Overview 14.14 C. R. Bard, Inc. 14.14.1 Company Overview 14.15 Nihon Kohden Corporation 14.15.1 Company Overview 15 Cardiovascular Devices Market Pipeline Products 16 Financial Deals Landscape 16.1 Acquisition 16.1.1 Beijing Best-Med Development Acquires Stake In Compumedics For US$0.5 Million 16.2 Asset Transactions 16.2.1 AngioDynamics Completes Acquisition Of Rights To Microwave Ablation Technology For US$16 Million 16.3 Equity Offerings 16.3.1 IM Medical Announces Private Placement Of Shares For US$0.2 Million 16.3.2 Allied Healthcare Completes Rights Offering Of Shares For US$15.6 Million 16.3.3 Uscom Completes Private Placement Of Shares For US$1 Million 16.3.4 Suda Announces Private Placement Of Units For US$0.1 Million 16.3.5 Uscom Completes Private Placement Of Shares For US$0.03 Million 16.3.6 Compumedics Completes Public Offering Of Shares For US$0.24 Million 16.3.7 Sunshine Heart Completes Public Offering Of Shares For US$15 Million 16.3.8 Sunshine Heart Completes Second Tranche Of Private Placement Of Shares For US$0.5 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Million 16.3.9 Allied Healthcare Completes Privates Placement Of Shares For US$2 Million 16.3.10 Allied Healthcare Completes Rights Issue Of Shares For US$3 Million 16.3.11 Uscom Announces Private Placement Of Shares For US$0.73 Million 16.3.12 Sunshine Heart Completes Public Offering Of Common Stock For US$21 Million 16.3.13 AtCor Medical Completes Private Placement Of Shares For US$0.2 Million 16.4 Partnerships 16.4.1 Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 16.4.2 Sun Biomedical Plans To Enter Into Licensing Agreement With Parvulus Suisse 16.4.3 Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems 16.4.4 Symetis Enters Into Licensing Agreement With Endoluminal Sciences For Transcatheter Aortic Valve Implantation 16.4.5 Coherex Medical Enters Into Distribution Agreement With Biosense Webster 16.4.6 Terumo Enters Into Co-Development Agreement With Kaneka For PTA Balloon Catheters 16.4.7 Terumo Enters Into Agreement With Shanghai AngioCare Medical Technolgy 16.4.8 Biosensors Extends Licensing Agreement With Terumo For BioMatrix Technology 16.5 Venture Financing 16.5.1 Protego Medical Raises US$1.9 Million In Venture Financing 17 Recent Developments 17.1 Corporate Communications 17.1.1 May 20, 2014: BioControl Medical’s FitNeS System Gets European Approval For Treatment-resistant Depression 17.1.2 Mar 20, 2014: Harvard Research Reveals EarlySense Monitoring System Reduces Length of Stay in the Hospital and ICU 17.1.3 Sep 24, 2013: Uscom Ltd : New Global Sales Manager Appointed 17.1.4 Sep 10, 2013: Phase 3 Data From The Medicines Companys Oritavancin Solo Trials Featured at ICAAC Conference 17.2 Financial Announcements 17.2.1 Dec 19, 2013: Withdrawal of NTCELL pre-clinical study 17.2.2 Sep 19, 2013: Algaeon Raises US$0.05 Million In Venture Financing 17.2.3 Jun 03, 2013: Precision Biologics Announces Presentation Of NPC-1C Phase IIA Data For Treatment Of Pancreatic And Colorectal Cancers At ASCO 2013 Annual Meeting 17.3 Government and Public Interest 17.3.1 Apr 11, 2014: Oncolytics Biotech Collaborators Present Translational Brain Cancer Clinical Data and Immunomodulatory Preclinical Research at UK Oncolytic Virus Conference 17.4 Other Significant Developments 17.4.1 Mar 18, 2014: Compumedics wins key $0.7m (EUR0.5m) deal in Europe 17.4.2 Mar 12, 2014: Compumedics gets boost in China with key $2.0m contracts Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
17.4.3 Nov 04, 2013: Tissue Therapies Completes Private Placement Of Shares For US$3 Million 17.5 Product News 17.5.1 Apr 16, 2014: AtCor Medical Receives Patent in USA 17.5.2 Feb 24, 2014: Uscom BP+ new hypertension gold standard in children 17.5.3 Jan 02, 2014: LeMaitre to Sell Direct-to-Hospital in Australia and Norway 17.5.4 Oct 09, 2013: 8 surgeons get approval to use cardiocel in adult patients 17.5.5 Jul 15, 2013: AtCor Medical Receives European Patent 18 Appendix 18.1 Research Methodology 18.1.1 Coverage 18.1.2 Secondary Research 18.1.3 Primary Research 18.1.4 Market Modeling and Forecasting 18.1.5 Company Share Analysis 18.1.6 Distribution Share Analysis 18.2 Expert Panel 18.3 Consulting 18.4 Contact Us 18.5 Disclaimer List of Tables Table 1: Cardiovascular Devices Market, Australia, Revenue ($m), USD Constant, 2005-2020 Table 2: Cardiovascular Devices Market, Australia, Category Contribution by Revenue ($m), 2012 Table 3: Cardiovascular Devices Market, Australia, Category Comparison by Revenue ($m), 2005-2020 Table 4: Cardiovascular Devices Market, Australia, Revenue ($m), USD Constant, Historic, 20052012 Table 5: Cardiovascular Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 20122020 Table 6: Cardiovascular Devices Market, Australia, Volume (Units), 2005-2020 Table 7: Cardiovascular Devices Market, Australia, Volume (Units), Historic, 2005-2012 Table 8: Cardiovascular Devices Market, Australia, Volume (Units), Forecast, 2012-2020 Table 9: Cardiovascular Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2011-2012 Table 10: Cardiac Assist Devices Market, Australia, Segment Contribution (%), 2012 Table 11: Cardiac Assist Devices Market, Australia, Revenue ($m), USD Constant, Historic, 20052012 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 12: Cardiac Assist Devices Market, Australia, Revenue ($m) USD Constant, Forecast, 20122020 Table 13: Cardiac Assist Devices Market, Australia, Volume (Units) by Segment, Historic, 20052012 Table 14: Cardiac Assist Devices Market, Australia, Volume (Units) by Segment, Forecast, 20122020 Table 15: Cardiac Assist Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 Table 16: Cardiac Assist Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2011-2012 Table 17: Cardiac Rhythm Management Market, Australia, Segment Contribution (%), 2012 Table 18: Cardiac Rhythm Management Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Table 19: Cardiac Rhythm Management Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Table 20: Cardiac Rhythm Management Market, Australia, Volume (Units) by Segment, Historic, 2005-2012 Table 21: Cardiac Rhythm Management Market, Australia, Volume (Units) by Segment, Forecast, 2012-2020 Table 22: Cardiac Rhythm Management Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 Table 23: Cardiac Rhythm Management Market, Australia, Company Share by Revenue ($m), USD Constant, 2011-2012 Table 24: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Table 25: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Table 26: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Volume (Units) by Segment, Historic, 2005-2012 Table 27: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Volume (Units) by Segment, Forecast, 2012-2020 Table 28: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 Table 29: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2011-2012 Table 30: Cardiovascular Prosthetic Devices Market, Australia, Segment Contribution (%), 2012 Table 31: Cardiovascular Prosthetic Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Table 32: Cardiovascular Prosthetic Devices Market, Australia, Revenue ($m) USD Constant, Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Forecast, 2012-2020 Table 33: Cardiovascular Prosthetic Devices Market, Australia, Volume (Units) by Segment, Historic, 2005-2012 Table 34: Cardiovascular Prosthetic Devices Market, Australia, Volume (Units) by Segment, Forecast, 2012-2020 Table 35: Cardiovascular Prosthetic Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 Table 36: Cardiovascular Prosthetic Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2011-2012 Table 37: Cardiovascular Surgery Market, Australia, Segment Contribution (%), 2012 Table 38: Cardiovascular Surgery Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Table 39: Cardiovascular Surgery Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Table 40: Cardiovascular Surgery Market, Australia, Volume (Units) by Segment, Historic, 20052012 Table 41: Cardiovascular Surgery Market, Australia, Volume (Units) by Segment, Forecast, 20122020 Table 42: Cardiovascular Surgery Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 Table 43: Cardiovascular Surgery Market, Australia, Company Share by Revenue ($m), USD Constant, 2011-2012 Table 44: Electrophysiology Market, Australia, Segment Contribution (%), 2012 Table 45: Electrophysiology Market, Australia, Revenue ($m), USD Constant, Historic, 20052012 Table 46: Electrophysiology Market, Australia, Revenue ($m) USD Constant, Forecast, 20122020 Table 47: Electrophysiology Market, Australia, Volume (Units) by Segment, Historic, 2005-2012 Table 48: Electrophysiology Market, Australia, Volume (Units) by Segment, Forecast, 2012-2020 Table 49: Electrophysiology Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 Table 50: Electrophysiology Market, Australia, Company Share by Revenue ($m), USD Constant, 2011-2012 Table 51: External Defibrillators Market, Australia, Revenue ($m), USD Constant, Historic, 20052012 Table 52: External Defibrillators Market, Australia, Revenue ($m) USD Constant, Forecast, 20122020 Table 53: External Defibrillators Market, Australia, Volume (Units) by Segment, Historic, 20052012 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 54: External Defibrillators Market, Australia, Volume (Units) by Segment, Forecast, 20122020 Table 55: External Defibrillators Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 Table 56: External Defibrillators Market, Australia, Company Share by Revenue ($m), USD Constant, 2011-2012 Table 57: Interventional Cardiology Market, Australia, Segment Contribution (%), 2012 Table 58: Interventional Cardiology Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Table 59: Interventional Cardiology Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Table 60: Interventional Cardiology Market, Australia, Volume (Units) by Segment, Historic, 2005-2012 Table 61: Interventional Cardiology Market, Australia, Volume (Units) by Segment, Forecast, 2012-2020 Table 62: Interventional Cardiology Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 Table 63: Interventional Cardiology Market, Australia, Company Share by Revenue ($m), USD Constant, 2011-2012 Table 64: Peripheral Vascular Devices Market, Australia, Segment Contribution (%), 2012 Table 65: Peripheral Vascular Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Table 66: Peripheral Vascular Devices Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Table 67: Peripheral Vascular Devices Market, Australia, Volume (Units) by Segment, Historic, 2005-2012 Table 68: Peripheral Vascular Devices Market, Australia, Volume (Units) by Segment, Forecast, 2012-2020 Table 69: Peripheral Vascular Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 Table 70: Peripheral Vascular Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2011-2012 Table 71: Prosthetic Heart Valves Market, Australia, Segment Contribution (%), 2012 Table 72: Prosthetic Heart Valves Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Table 73: Prosthetic Heart Valves Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Table 74: Prosthetic Heart Valves Market, Australia, Volume (Units) by Segment, Historic, 20052012 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 75: Prosthetic Heart Valves Market, Australia, Volume (Units) by Segment, Forecast, 2012-2020 Table 76: Prosthetic Heart Valves Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 Table 77: Prosthetic Heart Valves Market, Australia, Company Share by Revenue ($m), USD Constant, 2011-2012 Table 78: Cardiovascular Devices Market Pipeline Products Table 79: Beijing Best-Med Development Acquires Stake In Compumedics For US$0.5 Million Table 80: AngioDynamics Completes Acquisition Of Rights To Microwave Ablation Technology For US$16 Million Table 81: IM Medical Announces Private Placement Of Shares For US$0.2 Million Table 82: Allied Healthcare Completes Rights Offering Of Shares For US$15.6 Million Table 83: Uscom Completes Private Placement Of Shares For US$1 Million Table 84: Suda Announces Private Placement Of Units For US$0.1 Million Table 85: Uscom Completes Private Placement Of Shares For US$0.03 Million Table 86: Compumedics Completes Public Offering Of Shares For US$0.24 Million Table 87: Sunshine Heart Completes Public Offering Of Shares For US$15 Million Table 88: Sunshine Heart Completes Second Tranche Of Private Placement Of Shares For US$0.5 Million Table 89: Allied Healthcare Completes Privates Placement Of Shares For US$2 Million Table 90: Allied Healthcare Completes Rights Issue Of Shares For US$3 Million Table 91: Uscom Announces Private Placement Of Shares For US$0.73 Million Table 92: Sunshine Heart Completes Public Offering Of Common Stock For US$21 Million Table 93: AtCor Medical Completes Private Placement Of Shares For US$0.2 Million Table 94: Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology Table 95: Sun Biomedical Plans To Enter Into Licensing Agreement With Parvulus Suisse Table 96: Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems Table 97: Symetis Enters Into Licensing Agreement With Endoluminal Sciences For Transcatheter Aortic Valve Implantation Table 98: Coherex Medical Enters Into Distribution Agreement With Biosense Webster Table 99: Terumo Enters Into Co-Development Agreement With Kaneka For PTA Balloon Catheters Table 100: Terumo Enters Into Agreement With Shanghai AngioCare Medical Technolgy Table 101: Biosensors Extends Licensing Agreement With Terumo For BioMatrix Technology Table 102: Protego Medical Raises US$1.9 Million In Venture Financing Table 103: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
List of Figures Figure 1: Cardiovascular Devices Market, Australia, Revenue ($m), USD Constant, 2005-2020 Figure 2: Cardiovascular Devices Market, Australia, Revenue Mix ($m), 2012 Figure 3: Cardiovascular Devices Market, Australia, Category Contribution (%), 2012 Figure 4: Cardiovascular Devices Market, Australia, Category Comparison by Revenue ($m), 2005-2020 Figure 5: Cardiovascular Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Figure 6: Cardiovascular Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2012-2020 Figure 7: Cardiovascular Devices Market, Australia, Volume (Units), 2005-2020 Figure 8: Cardiovascular Devices Market, Australia, Volume (Units), Historic, 2005-2012 Figure 9: Cardiovascular Devices Market, Australia, Volume (Units), Forecast, 2012-2020 Figure 10: Cardiovascular Devices Market, Australia, Company Share (%), 2012 Figure 11: Cardiac Assist Devices Market, Australia, Revenue Mix ($m), 2012 Figure 12: Cardiac Assist Devices Market, Australia, Segment Contribution (%), 2012 Figure 13: Cardiac Assist Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Figure 14: Cardiac Assist Devices Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Figure 15: Cardiac Assist Devices Market, Australia, Volume (Units) by Segment, Historic, 20052012 Figure 16: Cardiac Assist Devices Market, Australia, Volume (Units) by Segment, Forecast, 20122020 Figure 17: Cardiac Assist Devices Market, Australia, Company Share (%), 2012 Figure 18: Cardiac Rhythm Management Market, Australia, Revenue Mix ($m), 2012 Figure 19: Cardiac Rhythm Management Market, Australia, Segment Contribution (%), 2012 Figure 20: Cardiac Rhythm Management Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Figure 21: Cardiac Rhythm Management Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Figure 22: Cardiac Rhythm Management Market, Australia, Volume (Units) by Segment, Historic, 2005-2012 Figure 23: Cardiac Rhythm Management Market, Australia, Volume (Units) by Segment, Forecast, 2012-2020 Figure 24: Cardiac Rhythm Management Market, Australia, Company Share (%), 2012 Figure 25: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue ($m), Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
USD Constant, Historic, 2005-2012 Figure 26: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Figure 27: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Volume (Units) by Segment, Historic, 2005-2012 Figure 28: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Volume (Units) by Segment, Forecast, 2012-2020 Figure 29: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Company Share (%), 2012 Figure 30: Cardiovascular Prosthetic Devices Market, Australia, Revenue Mix ($m), 2012 Figure 31: Cardiovascular Prosthetic Devices Market, Australia, Segment Contribution (%), 2012 Figure 32: Cardiovascular Prosthetic Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Figure 33: Cardiovascular Prosthetic Devices Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Figure 34: Cardiovascular Prosthetic Devices Market, Australia, Volume (Units) by Segment, Historic, 2005-2012 Figure 35: Cardiovascular Prosthetic Devices Market, Australia, Volume (Units) by Segment, Forecast, 2012-2020 Figure 36: Cardiovascular Prosthetic Devices Market, Australia, Company Share (%), 2012 Figure 37: Cardiovascular Surgery Market, Australia, Revenue Mix ($m), 2012 Figure 38: Cardiovascular Surgery Market, Australia, Segment Contribution (%), 2012 Figure 39: Cardiovascular Surgery Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Figure 40: Cardiovascular Surgery Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Figure 41: Cardiovascular Surgery Market, Australia, Volume (Units) by Segment, Historic, 2005-2012 Figure 42: Cardiovascular Surgery Market, Australia, Volume (Units) by Segment, Forecast, 2012-2020 Figure 43: Cardiovascular Surgery Market, Australia, Company Share (%), 2012 Figure 44: Electrophysiology Market, Australia, Revenue Mix ($m), 2012 Figure 45: Electrophysiology Market, Australia, Segment Contribution (%), 2012 Figure 46: Electrophysiology Market, Australia, Revenue ($m), USD Constant, Historic, 20052012 Figure 47: Electrophysiology Market, Australia, Revenue ($m) USD Constant, Forecast, 20122020 Figure 48: Electrophysiology Market, Australia, Volume (Units) by Segment, Historic, 2005-2012 Figure 49: Electrophysiology Market, Australia, Volume (Units) by Segment, Forecast, 2012Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2020 Figure 50: Electrophysiology Market, Australia, Company Share (%), 2012 Figure 51: External Defibrillators Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Figure 52: External Defibrillators Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Figure 53: External Defibrillators Market, Australia, Volume (Units) by Segment, Historic, 20052012 Figure 54: External Defibrillators Market, Australia, Volume (Units) by Segment, Forecast, 20122020 Figure 55: External Defibrillators Market, Australia, Company Share (%), 2012 Figure 56: Interventional Cardiology Market, Australia, Revenue Mix ($m), 2012 Figure 57: Interventional Cardiology Market, Australia, Segment Contribution (%), 2012 Figure 58: Interventional Cardiology Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Figure 59: Interventional Cardiology Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Figure 60: Interventional Cardiology Market, Australia, Volume (Units) by Segment, Historic, 2005-2012 Figure 61: Interventional Cardiology Market, Australia, Volume (Units) by Segment, Forecast, 2012-2020 Figure 62: Interventional Cardiology Market, Australia, Company Share (%), 2012 Figure 63: Peripheral Vascular Devices Market, Australia, Revenue Mix ($m), 2012 Figure 64: Peripheral Vascular Devices Market, Australia, Segment Contribution (%), 2012 Figure 65: Peripheral Vascular Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Figure 66: Peripheral Vascular Devices Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Figure 67: Peripheral Vascular Devices Market, Australia, Volume (Units) by Segment, Historic, 2005-2012 Figure 68: Peripheral Vascular Devices Market, Australia, Volume (Units) by Segment, Forecast, 2012-2020 Figure 69: Peripheral Vascular Devices Market, Australia, Company Share (%), 2012 Figure 70: Prosthetic Heart Valves Market, Australia, Revenue Mix ($m), 2012 Figure 71: Prosthetic Heart Valves Market, Australia, Segment Contribution (%), 2012 Figure 72: Prosthetic Heart Valves Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 Figure 73: Prosthetic Heart Valves Market, Australia, Revenue ($m) USD Constant, Forecast, 2012-2020 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 74: Prosthetic Heart Valves Market, Australia, Volume (Units) by Segment, Historic, 2005-2012 Figure 75: Prosthetic Heart Valves Market, Australia, Volume (Units) by Segment, Forecast, 2012-2020 Figure 76: Prosthetic Heart Valves Market, Australia, Company Share (%), 2012 Figure 77: GlobalData Epidemiology-Based Forecasting Model Figure 78: GlobalData Capital Equipment-Based Forecasting Model Figure 79: Primary Interviews by Participant Type (%)
Related reports: Global Breath Analyzers Market 2014-2018 Global Cell Culture Market 2014-2018 Healthcare and Medical Market Research
About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is one-stop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Australia Cardiovascular Devices Market Outlook to 2020 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others http://www.jsbmarketresearch.com/healthcare-medical/r-Australia-Cardiovascular-DevicesMarket-Outlook-to-2020-Cardiac-Rhythm-Management-Interventional-Cardiology-PeripheralVascular-Devices-Electrophysiology-Prosthetic-Heart-Valves-and-Others-114978 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/